Please complete the CAPTCHA to continue
@arbor.bio
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Greg Hoffman is listed as Chief Scientific Officer at Deep Genomics at Deep Genomics, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at arbor.bio and a matched LinkedIn profile for Greg Hoffman.
Greg Hoffman previously worked as Chief Scientific Officer at Deep Genomics and Vice President Platform Biology at Deep Genomics. Greg Hoffman holds Phd, Biophysics from Cornell University.
This section adds company-level context without repeating Greg Hoffman's masked contact details.
AeroLeads found 1 current-domain work email signal for Greg Hoffman. Compare company email patterns before reaching out.
Experienced leader in discovery and platform development for cell and gene therapy. Trained biophysicist & cell biologist with a career focus on applying innovative technologies to study the molecular basis of disease and develop medicines. 10+ years industry experience leading teams focused on genomic screening for early target discovery, small molecule discovery, synthetic biology, and cell and gene therapy. Effective leadership in establishing new technologies, building collaborative interdisciplinary teams, and building biotech and academic partnerships.
Listed skills include Cell Biology, Drug Discovery, Molecular Biology, Biochemistry, and 13 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Toronto, CA
Deep Genomics is an interdisciplinary team of machine learning and drug development scientists working to decode RNA biology, discover novel targets, and design and develop oligo-based therapeutics. Working with partners, we apply our AI Foundation Models to accelerate discovery and improve the success of translating these discoveries to the clinic.
Cambridge, Massachusetts, US
At Arbor Biotechnologies, we are uncovering novel gene editors and developing them into powerful tools in our quest for curative treatments for previously incurable genetic disease. The Discovery & Platform team uses high-throughput screening capabilities to characterize novel gene editing enzymes identified by Arbor’s powerful computational search.
Cambridge, MA, US
I lead the Discovery Group at Obsidian Therapeutics, where we are pioneering the development of controllable cell and gene therapies using our cytoDRiVE technology to deliver transformative outcomes for patients with intractable diseases. The Discovery team applies state-of-the-art functional screening technologies to identify new target opportunities and.
Seattle, Washington, US
Responsible for building technology platforms to drive all stages of our Sana's cell & gene therapies pipeline, from early discovery through scale-up and manufacturing across multiple sites including Cambridge, San Francisco, & Seattle.
Basel, Baselstadt, CH
I lead the Technologies Targets and Leads (T2L) group in Screening Sciences at NIBR focused on developing and deploying novel screening technologies for target & lead discovery. Our goal is to identify proprietary therapeutic targets for the NIBR pipeline in areas of high unmet medical and drive these projects through the early phase of lead discovery in.
Boston, MA, US
LAM Foundation Postdoctoral Fellow (Nov. 2004-May 2011) Principal Investigator: Dr. John BlenisElucidating the mechanisms of growth factor and nutrient regulation of mTORC1Helen Hay Whitney Postdoctoral Fellow (Oct. 2002 – Oct. 2004) Principal Investigator: Dr. Marc KirschnerBiochemical studies of MAP-kinase signal specificity in Xenopus egg extracts
Quick answers generated from the profile data available on this page.
Greg Hoffman works for Deep Genomics.
Greg Hoffman is listed as Chief Scientific Officer at Deep Genomics at Deep Genomics.
AeroLeads has found 1 work email signal at @arbor.bio for Greg Hoffman at Deep Genomics.
Greg Hoffman is based in Cambridge, Massachusetts, United States while working with Deep Genomics.
Greg Hoffman has worked for Deep Genomics, Arbor Biotechnologies, Obsidian Therapeutics, Sana Biotechnology, Inc., and Novartis Institutes For Biomedical Research.
You can use AeroLeads to view verified contact signals for Greg Hoffman at Deep Genomics, including work email, phone, and LinkedIn data when available.
Greg Hoffman holds Phd, Biophysics from Cornell University.
Greg Hoffman is listed with skills including Cell Biology, Drug Discovery, Molecular Biology, Biochemistry, Cell Culture, High Throughput Screening, Cell, and Assay Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts